Woman’s Hospital First US Site in International Trial for Oli Sensor to Detect Postpartum Hemorrhage
• Woman’s Hospital in Louisiana launched as the first US site in Baymatob's Oli Study, enrolling over 130 patients to test a wearable sensor for early postpartum hemorrhage detection during labor. • The trial aims to enroll 1000 women across five US sites including University of Colorado, Columbia University, Ohio State, and UPMC Magee-Women’s, with FDA clearance submission planned by year-end. • Postpartum hemorrhage is the leading cause of preventable maternal death globally; pilot results showed promise for the Oli device.
Read original · womans.org




